FindTrial
Sign In

A Phase II, double-blind, parallel-group comparison study of S-556971 in patients with dyslipidemia

A Phase II, double-blind, parallel-group comparison study of S-556971 in patients with dyslipidemia

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080222525
Enrollment
Unknown
Registered
2014-06-17
Start date
2014-06-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemia

Interventions

investigational material(s) Generic name etc : S-556971 INN of investigational material : Therapeutic category code : 218 Agents for hyperlipidemias Dosage and Administration for Investigational mate

Sponsors

SHIONOGI & CO., LTD.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with dyslipidemia classified into category I and category II for primary prevention defined by Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2012.

Exclusion criteria

Exclusion criteria: Patients with secondary dyslipidemia. Patients with severe hepatic, renal, cardiac, respiratory, or blood disorders.

Design outcomes

Primary

MeasureTime frame
Efficacy Safety—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026